Efficacy and Safety of Pirfenidone in CTD-ILD

Clinical trial NCT05505409 · UNKNOWN

Trial details

NCT number: NCT05505409
Sponsor: Qilu Hospital of Shandong University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Pirfenidone Connective Tissue Diseases Interstitial Lung Disease

Start date: 2022-06-22
Primary completion: 2025-06-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.